# GPT-5.4 (R2) Review

**Role:** External referee review
**Model:** openai/gpt-5.4
**Paper:** paper.pdf
**Timestamp:** 2026-03-25T16:48:26.133172
**Route:** OpenRouter + LaTeX
**Review mode:** Tri-model (3 independent reviewers)
**Tokens:** 13886 in / 5136 out
**Response SHA256:** 336f1cddc00f31b5

---

This paper asks an important and policy-relevant question: do “safe country of origin” (SCO) designations change adjudication, or mainly deter applications? The distinction between decision-stage and selection-stage effects is potentially valuable, and the paper assembles a novel cross-country panel with rich institutional variation. The core empirical finding—that the large raw correlation between SCO status and low recognition rates disappears after adding saturated fixed effects—is interesting. The application-side results are also suggestive.

That said, in its current form I do not think the paper is publication-ready for a top general-interest journal or AEJ:EP. The main reason is not that the question is unimportant, but that the causal interpretation remains materially under-validated. The paper’s strongest claim is about a null effect on recognition rates, yet the design faces unresolved timing and estimator-choice issues, and the paper’s own staggered-DiD robustness check produces a statistically significant negative effect that is inconsistent with the headline conclusion. In addition, the system-wide deterrence result is not cleanly identified and is currently overstated relative to the evidence.

Below I focus on scientific substance and publication readiness.

---

## 1. Identification and empirical design

### 1.1 Main triple-difference design: promising but not yet fully credible

The main specification is

\[
\text{RecogRate}_{cjt} = \beta \cdot \text{SCO}_{cjt} + \gamma_{cj} + \delta_{ct} + \theta_{jt} + \varepsilon_{cjt}
\]

with origin-destination pair FE, origin-year FE, and destination-year FE (Section 4). This is a sensible starting design. The fixed effects absorb many first-order confounds: time-invariant bilateral differences, origin shocks, and destination shocks.

However, for the paper’s causal claim—“designation has no causal effect on recognition rates”—the design still has several unresolved problems:

#### (a) Timing mismatch between treatment and outcome
The outcome is **first-instance decisions in year \(t\)**, but treatment is coded at the **calendar-year origin-destination level**. This is problematic because decisions in year \(t\) are often made on applications filed before year \(t\), and many of the policy changes occur mid-year (e.g., Germany October 2015; Austria October 2014; Belgium by decree dates; Section 2 and Data Appendix). With annual decision data, the treatment date and the outcome cohort are not aligned.

This matters a lot for the adjudication claim. If SCO affects procedure or burden of proof at the time a case is processed, annual first-instance decisions mix:
- pre-policy applications decided post-policy,
- post-policy applications decided pre-full-implementation,
- partial-year treatment exposure.

So the zero estimate may reflect attenuation from severe timing mismeasurement rather than true absence of an effect.

This is, in my view, the paper’s single biggest design issue.

#### (b) Staggered adoption concerns are not resolved by the current exposition
The paper correctly notes that staggered timing creates “forbidden comparisons” in TWFE (Section 4), but then retains the FE model as primary and relegates the Callaway-Sant’Anna estimate to a sensitivity check. This is not sufficient because the paper’s own CS result is **ATT = -0.049 (SE = 0.017)** (Section 5.5 / Table 5), which is economically nontrivial and statistically significant.

That divergence is central, not peripheral. If one estimator says essentially zero and another says a 5 pp reduction, the paper cannot simply declare the null as the main conclusion. A top-field-journal version would need a principled estimator strategy where the preferred specification is robust to staggered timing and treatment heterogeneity.

#### (c) Event-study evidence does not convincingly validate parallel trends
The event study is restricted to treated pairs and omits origin×year FE “to preserve event-time variation” (Section 4.2; Figure 1). This is understandable mechanically, but substantively it weakens the diagnostic value of the event study relative to the main model. The pre-period coefficients at \(t-4\) and \(t-3\) are positive and marginally significant; the paper interprets that as governments responding after a peak. That may be true, but it also means treatment timing is endogenous to evolving outcome dynamics. The “clean” \(t-2\) coefficient is not enough to validate the identifying assumption.

In short, the event study does not provide strong reassurance that, absent designation, treated pairs would have followed the same path as the identifying controls in the saturated DDD.

#### (d) Treatment and control groups are highly non-comparable in substantive terms
The treated origins are largely Balkan and other low-recognition countries; the never-treated controls are conflict origins such as Syria, Afghanistan, Iraq, Eritrea, Iran, Somalia, etc. (Section 3). Origin×year FE absorbs common origin shocks, so this is not a mechanical fatal flaw for identification. But substantively, it raises concern that identification is coming from a narrow and unusual support set. It would help to know whether the results survive in designs that compare only among ever-treated origins, or only within the set of plausible “safe-country-candidate” origins.

As written, the paper does not sufficiently establish that the identifying variation is among comparable units.

#### (e) Partial-year treatment coding is likely consequential
The paper explicitly codes annual treatment, while many adoptions happen late in the year (e.g., October/November). Yet those years appear to be coded as treated. This creates classical attenuation at best, and nonclassical contamination if recognition rates and application volumes are seasonal. A top-journal paper needs either:
- a monthly/quarterly panel, or
- a clear rule that drops adoption years / defines treatment as starting in the first full post year, with robustness showing stability.

At present, treatment timing and data coverage are not coherent enough for strong causal claims.

---

## 2. Inference and statistical validity

### 2.1 Main inference is better than average, but still incomplete relative to the design issues

The paper reports clustered SEs, a pairs cluster bootstrap, and randomization inference (Section 4 and Table 5). With 22 destination clusters, this is thoughtful and appropriate.

That said, valid inference is not only about SEs; it also depends on the estimator matching the treatment structure. Here the main concern is not under-clustering but **estimator validity under staggered adoption and heterogeneity**.

### 2.2 The significant CS estimate materially undermines the headline null
The paper cannot pass statistical-validity scrutiny while treating a statistically significant alternative estimator as a minor curiosity. The result is not just “somewhat more negative”; it is meaningfully different from zero and from the headline estimate.

The current explanation—that CS has small groups, drops always-treated units, and uses an unbalanced panel—is plausible but insufficient. Those features do not license dismissing the estimate. They instead imply that the paper has not yet established which estimand is policy-relevant and which estimator is credible.

At minimum the paper needs:
- a primary estimator that is robust to staggered timing,
- cohort-specific effects,
- transparent decomposition of where the TWFE/DDD and CS differences come from,
- and a discussion of what population each estimate pertains to.

### 2.3 Weighted specification may use endogenous weights
Column (3) of Table 2 weights by total decisions. But if SCO affects applications and therefore later decisions, total decisions are potentially post-treatment and endogenous. That makes the weighted estimate difficult to interpret causally. This is not fatal if clearly labeled descriptive, but as presented it reads as a robustness check when it may introduce bias.

### 2.4 Fractional outcome and cell-size threshold
Recognition rate is a bounded fraction based on varying cell denominators. OLS on rates can be acceptable, but given large denominator heterogeneity and the ≥10-decision threshold, more attention is needed to whether the results are driven by noisy small cells or by denominator changes. The threshold itself may induce sample-selection changes if treatment affects decision counts. The paper mentions this threat (Section 4.2) but does not show the actual robustness table.

### 2.5 Power discussion is somewhat overstated
The MDE of 7.2 pp is informative, but the abstract and conclusion sometimes imply the null is “precisely estimated zero.” I would be more cautious. The 95% bootstrap CI of roughly [-5.7 pp, +6.4 pp] rules out very large adjudication effects, but not moderate ones. And the existence of the significant CS estimate makes any claim of precise null especially difficult to sustain.

---

## 3. Robustness and alternative explanations

### 3.1 Recognition-rate null may be driven by outcome mismeasurement
Because the outcome is annual decisions rather than application cohorts, the most important alternative explanation for the null is not substantive “no effect,” but measurement attenuation from timing mismatch. This alternative is not adequately addressed.

A stronger paper would show:
- drop-year-of-adoption results,
- first-full-post-year treatment coding,
- leads/lags under multiple coding conventions,
- if possible, processing-time evidence showing when designated-origin cases actually enter the decision stock.

### 3.2 The application-deterrence result is plausible but only moderately strong
The own-designation deterrence estimate in Table 3, column (1), is -0.428 with SE 0.249. This is borderline evidence, not a firmly established effect. It is fair to describe as suggestive evidence of reduced applications, but the paper’s tone in the abstract and conclusion is stronger than the estimate warrants.

Also, using log(applications+1) with annual cells is standard enough, but the paper should test count-model robustness (e.g., PPML) and robustness to zero-heavy cells.

### 3.3 The “system-wide deterrence” claim is not causally identified
This is the paper’s weakest substantive claim. As the authors acknowledge, the “share other designating” regressor varies at the origin×year level and the model omits origin×year FE (Table 3, column 2). That means the estimate is vulnerable to exactly the origin-level confounding the main specification was designed to eliminate: improving conditions in origin countries can both induce designation elsewhere and reduce applications everywhere.

The paper acknowledges this caveat, but then still features the system-wide deterrence result in the abstract, introduction, and conclusion as if it were close to causal. That is too strong. At present this is an interesting correlation, not convincing evidence against diversion.

### 3.4 Mechanism claims are not sufficiently separated from reduced-form findings
The paper interprets the null as evidence that bureaucrats do not change how they judge claims, and the application effect as evidence of informational deterrence. Those are plausible mechanisms, but the evidence is reduced-form and indirect:
- no case-level information on claim composition,
- no processing times,
- no accelerated-procedure usage,
- no appeals,
- no direct evidence on applicant beliefs or information.

The paper should calibrate mechanism language much more carefully.

### 3.5 Protection-type substitution result is intriguing but weak
The decomposition in Table 4 is potentially interesting, but the evidence is noisy and the signs do not add up cleanly:
- total recognition: -0.004
- Geneva: +0.045
- subsidiary/humanitarian: -0.080

The implied sum is not close to zero, and the sample size differs in column (3). The paper should clarify whether missingness or coding differences explain this, and should not lean heavily on “reclassification” without a formal test of equality/opposite offset. As written, this section over-interprets suggestive coefficients.

---

## 4. Contribution and literature positioning

### 4.1 Contribution is potentially strong
The paper’s central conceptual distinction—policy labels can affect selection into the system more than decisions within the system—is interesting and potentially of broader interest. The asylum-policy setting is policy-relevant and topical given the EU common list.

### 4.2 The contribution currently outpaces the evidence
The introduction repeatedly states that the paper “shows” the standard explanation is wrong and provides the “first causal estimates on both margins for the same instrument.” That is too categorical given the unresolved identification issues above.

A more defensible framing would be:
- the paper provides new cross-country evidence that the raw adjudication gap largely disappears under rich fixed effects,
- while application volumes appear to decline following designation,
- but evidence on system-wide spillovers and exact adjudication effects remains less definitive.

### 4.3 Literature coverage is decent but could be strengthened on methods and asylum adjudication
The paper cites core asylum-policy work and Callaway-Sant’Anna. I would strongly recommend adding and engaging with:

#### On staggered DiD / event-study identification
- Sun, Liyang and Sarah Abraham (2021), “Estimating Dynamic Treatment Effects in Event Studies with Heterogeneous Treatment Effects,” *Journal of Econometrics*.
- de Chaisemartin, Clément and Xavier D’Haultfoeuille (2020), “Two-Way Fixed Effects Estimators with Heterogeneous Treatment Effects,” *AER*.
- Borusyak, Jaravel, and Spiess (2024), “Revisiting Event Study Designs,” *Review of Economic Studies*.

These are essential given the estimator divergence.

#### On migration/asylum policy effects
Depending on the exact bibliography, the paper would benefit from engaging more deeply with work on asylum recognition determinants, bureaucratic variation, and policy deterrence beyond the headline cross-country studies already cited.

#### On safe-country law/procedure and implementation heterogeneity
The paper cites AIDA/EUAA and Costello, but should more directly discuss heterogeneity in implementation intensity across member states, because that is central to interpreting the null.

---

## 5. Results interpretation and claim calibration

### 5.1 The paper over-claims on the main null
Statements such as:
- “the explanation is wrong,”
- “the correlation is entirely compositional,”
- “designations have no causal effect on recognition rates,”
- “a precisely estimated zero”

go beyond what the evidence currently supports.

A more accurate interpretation is:
- the large raw gap is substantially reduced or eliminated in the preferred saturated FE specification,
- but treatment timing misalignment and estimator sensitivity leave some uncertainty about the true adjudication effect.

### 5.2 The abstract is too strong relative to the application evidence
The abstract says designations “reduce applications by approximately 35%” as though this were firmly established. But the own-designation estimate is only marginally precise (p ≈ 0.10 from the reported SE), and the system-wide result is not cleanly causal. The abstract should be toned down unless the application results are significantly reinforced.

### 5.3 Policy implications are overstated
The paper draws strong implications for the 2025 EU common list, arguing harmonization “will not improve decision consistency” but may amplify deterrence. That conclusion is premature. The evidence pertains to national designations under heterogeneous implementation and annual aggregate data; it does not identify the effect of an EU-wide harmonized regime. The policy discussion should be more conditional.

### 5.4 Internal inconsistency between null and negative CS estimate
This is the most important interpretive problem. The paper cannot both:
- insist the causal adjudication effect is essentially zero,
- and report a significant -4.9 pp ATT from a heterogeneity-robust design,
without fully reconciling the difference.

Until that is resolved, the conclusions must be much more cautious.

---

## 6. Actionable revision requests

### 1. Must-fix issues before acceptance

#### 1. Resolve treatment timing and outcome alignment
- **Issue:** Annual treatment coding is poorly aligned with annual first-instance decisions, especially with mid-year adoptions.
- **Why it matters:** This can mechanically attenuate adjudication effects and invalidate the main null.
- **Concrete fix:** Recode treatment to begin in the first full post-designation year; separately drop adoption years; show robustness across coding rules. If possible, move to monthly/quarterly data or exploit more precise decision/application timing. At minimum, provide a clear cohort-timing discussion of how decisions map to applications and policy exposure.

#### 2. Make a staggered-adoption-robust estimator primary, not ancillary
- **Issue:** The paper’s own CS estimate is statistically significant and inconsistent with the headline result.
- **Why it matters:** A paper cannot claim a robust null when robust estimators disagree materially.
- **Concrete fix:** Re-estimate the main effect using a preferred heterogeneity-robust approach as the primary specification (e.g., stacked DiD, imputation/BJS-style estimator, Sun-Abraham-style dynamics adapted to the design, or a clearly justified CS-based estimand). Explain exactly why estimates differ across methods.

#### 3. Reconcile TWFE/DDD and CS results transparently
- **Issue:** The paper currently dismisses the CS result rather than investigating it.
- **Why it matters:** This is central to the adjudication claim.
- **Concrete fix:** Decompose differences in sample, cohort composition, always-treated units, and weighting. Report cohort-specific ATTs and event-study profiles by cohort. Show whether effects are concentrated in early adopters or specific destinations.

#### 4. Downgrade or redesign the system-wide deterrence claim
- **Issue:** The “share other designating” regression is confounded by origin-year shocks.
- **Why it matters:** This claim is currently too weakly identified to feature prominently.
- **Concrete fix:** Either (i) move this result to a suggestive appendix exercise and tone down all associated claims, or (ii) redesign using more credible exogenous variation, e.g., instruments/political timing or event-based spillover designs with origin-specific controls and pre-trend tests.

#### 5. Address sample selection from the ≥10-decision threshold
- **Issue:** Thresholding on decisions may itself respond to treatment via application or processing changes.
- **Why it matters:** This may induce selection into the estimation sample.
- **Concrete fix:** Show robustness to no threshold / alternative thresholds / inverse-variance weighting / denominator-based models, and report whether treatment affects the probability a cell enters the sample.

### 2. High-value improvements

#### 6. Strengthen the event-study design
- **Issue:** The current treated-only event study without origin×year FE is not a close diagnostic for the main identifying assumption.
- **Why it matters:** Parallel-trends validation is currently incomplete.
- **Concrete fix:** Provide alternative dynamic specifications under robust staggered estimators; show pre-trends for the preferred estimand; consider stacked event studies.

#### 7. Clarify the interpretation of weighted estimates
- **Issue:** Weighting by total decisions may be endogenous.
- **Why it matters:** Readers may misread it as a clean robustness check.
- **Concrete fix:** Label weighted results as descriptive unless weights are predetermined; consider pre-treatment average weights if weighting is substantively important.

#### 8. Provide stronger robustness for applications
- **Issue:** The own-designation application effect is suggestive but not yet fully persuasive.
- **Why it matters:** It is the paper’s main positive result.
- **Concrete fix:** Add PPML/count-model robustness, adoption-year coding robustness, and perhaps leads/lags to show dynamics of applications around designation. If possible, separate first-time applications from total decisions more carefully in timing.

#### 9. Better distinguish adjudication from composition
- **Issue:** The headline mechanism is selection, but the evidence is indirect.
- **Why it matters:** The paper’s broad contribution hinges on this distinction.
- **Concrete fix:** Where possible, add compositional proxies: applicant demographics, origin subgroups, repeat applications, processing times, or appeal rates. Even partial evidence would greatly strengthen the interpretation.

#### 10. Revisit the protection-type decomposition
- **Issue:** The decomposition is suggestive but internally unclear.
- **Why it matters:** It currently invites over-interpretation.
- **Concrete fix:** Clarify denominator/sample differences across columns and test whether effects across protection types sum consistently. Present this as exploratory unless better validated.

### 3. Optional polish

#### 11. Tighten claim language throughout
- **Issue:** Current language is too categorical.
- **Why it matters:** Overstated claims reduce credibility.
- **Concrete fix:** Replace “shows”/“wrong”/“entirely compositional” with more calibrated language unless stronger identification is established.

#### 12. Clarify estimand and support
- **Issue:** It is not fully clear for which countries/origins the identifying variation is strongest.
- **Why it matters:** External validity and interpretation depend on support.
- **Concrete fix:** Add a concise discussion/table showing treated cohorts, always-treated units, never-treated units, and which comparisons identify the coefficient.

---

## 7. Overall assessment

### Key strengths
- Important and timely policy question.
- Potentially valuable conceptual distinction between decision-stage and application-stage effects.
- Rich cross-country panel and substantial effort in coding designation events.
- Thoughtful attempt to go beyond default clustered SEs with bootstrap and randomization inference.
- The disappearance of the raw SCO-recognition correlation under saturated FE is genuinely interesting.

### Critical weaknesses
- Timing mismatch between annual treatment coding and annual first-instance decisions is a major threat to identification.
- Main estimator is not convincingly robust to staggered adoption; the paper’s own CS result materially contradicts the headline null.
- Parallel-trends validation is not strong enough.
- The system-wide deterrence result is not cleanly identified and is overstated.
- Some interpretations (“bureaucrats do not change judgments,” “precisely estimated zero”) are stronger than the evidence supports.

### Publishability after revision
I think this project is potentially salvageable and could become a strong field-journal paper, possibly with broader appeal if the identification is substantially strengthened. But it is not close to acceptance in current form. The key is to make the adjudication result robust to timing and staggered-adoption concerns, and to scale back or better identify the spillover claim.

DECISION: MAJOR REVISION